Free Trial

Clearside Biomedical (CLSD) Earnings Date, Estimates & Call Transcripts

Clearside Biomedical logo
$1.01
-0.01 (-0.98%)
(As of 11/1/2024 ET)

Clearside Biomedical Latest Earnings Summary

Upcoming Q3
Earnings Date
Nov. 12After Market ClosesConfirmed
Actual EPS
(Aug. 12)
-$0.10 Beat By $0.04
Consensus EPS
(Aug. 12)
-$0.14

Clearside Biomedical issued Q2 2024 earnings on August 12, 2024, reporting an EPS of -$0.10, which topped analysts' consensus estimates of -$0.14 by $0.04. Quarterly revenue was reported to be $0.09 million, below analyst estimates of $0.25 million. With a trailing EPS of -$0.50, Clearside Biomedical's earnings are expected to decrease next year, from ($0.56) to ($0.57) per share.

CLSD Upcoming Earnings

Clearside Biomedical's next earnings date is scheduled for Tuesday, November 12, 2024, with a conference call scheduled for at 4:30 PM ET. Interested parties can register for or listen to the call.

Get Clearside Biomedical Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Clearside Biomedical and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

CLSD Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CLSD Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Clearside Biomedical Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242-$0.16-$0.12-$0.14
Q2 20242-$0.15-$0.12-$0.14
Q3 20242-$0.13-$0.12-$0.13
Q4 20242-$0.13-$0.12-$0.13
FY 20248-$0.57-$0.48-$0.53
Q1 20251-$0.13-$0.13-$0.13
Q2 20251-$0.14-$0.14-$0.14
Q3 20251-$0.14-$0.14-$0.14
Q4 20251-$0.13-$0.13-$0.13
FY 20254($0.54)($0.54)($0.54)

Clearside Biomedical Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
11/12/2024
(Confirmed)
-------  
8/12/2024Q2 2024-$0.14-$0.10+$0.04-$0.10$0.25M$0.09M  
5/9/2024Q1 2024-$0.14-$0.17 -$0.03-$0.17$0.98M$0.23M      
3/12/2024Q4 2023-$0.10-$0.08+$0.02-$0.08$3.40M$6.35M  
11/13/2023Q3 2023-$0.16-$0.15+$0.01-$0.15$0.22M$0.86M      
8/14/2023Q2 2023-$0.14-$0.15 -$0.01-$0.15$0.21M$1.02M  
5/11/2023Q1 2023-$0.14-$0.15 -$0.01-$0.15--  
3/9/2023Q4 2022-$0.13-$0.16 -$0.03-$0.16$0.16M$0.33M  
11/9/2022Q3 2022$0.04-$0.13 -$0.17-$0.13$16.50M$0.27M  

Clearside Biomedical Earnings - Frequently Asked Questions

Clearside Biomedical has confirmed that its next quarterly earnings data will be published on Tuesday, November 12th, 2024. Learn more on CLSD's earnings history.

In the previous quarter, Clearside Biomedical (NASDAQ:CLSD) reported ($0.10) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.14) by $0.04. Learn more on analysts' earnings estimate vs. CLSD's actual earnings.

Clearside Biomedical (NASDAQ:CLSD) has a recorded annual revenue of $7.52 million.

Clearside Biomedical (NASDAQ:CLSD) has a recorded net income of -$32.49 million. CLSD has generated -$0.50 earnings per share over the last four quarters.

Clearside Biomedical's earnings are expected to decrease from ($0.56) per share to ($0.57) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:CLSD) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners